Local ascorbate administration augments NO- and non-NO-dependent reflex cutaneous vasodilation in hypertensive humans

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 2, 2007, Pages

  Holowatz, Lacy A ^a,b   Kenney, W Larry ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b Women's Health and Exercise Laboratory   (United States)

Author keywords

Essential hypertension; Oxidative stress; Skin blood flow; Temperature regulation; Vitamin C

Indexed keywords

(2 BORONOETHYL) LEVO CYSTEINE HYDROCHLORIDE; ANTIOXIDANT; ARGINASE; ARGINASE INHIBITOR; ASCORBIC ACID; ENZYME INHIBITOR; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CELL TRANSFER; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME INHIBITION; ERYTHROCYTE; FEMALE; HEATING; HUMAN; HYPERTENSION; LASER DOPPLER FLOWMETRY; MALE; MEAN ARTERIAL PRESSURE; MICRODIALYSIS; PRIORITY JOURNAL; SKIN BLOOD FLOW; VASODILATATION;

ADMINISTRATION, CUTANEOUS; ANTIOXIDANTS; ARGINASE; ASCORBIC ACID; BLOOD FLOW VELOCITY; BLOOD VESSELS; BORONIC ACIDS; CASE-CONTROL STUDIES; ENZYME INHIBITORS; FEMALE; FEVER; HUMANS; HYPERTENSION; LASER-DOPPLER FLOWMETRY; MALE; MICRODIALYSIS; MIDDLE AGED; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REFLEX; SKIN; TIME FACTORS; VASODILATION;

EID: 34547857426     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00295.2007     Document Type: Article

References (38)

1. American Heart Association. Heart Disease and Stroke Statistics: 2006 Update. Dallas, TX: American Heart Association, 2006.
2. Bailey SR, Mitra S, Flavahan S, Flavahan NA. Reactive oxygen species from smooth muscle mitochondria initiate cold-induced constriction of cutaneous arteries. Am J Physiol Heart Circ Physiol 289: H243-H250, 2005.
3. Bennett LA, Johnson JM, Stephens DP, Saad AR, Kellogg DL Jr. Evidence for a role for vasoactive intestinal peptide in active vasodilatation in the cutaneous vasculature of humans. J Physiol 552: 223-232, 2003.
4. Braverman IM, Keh A, Goldminz D. Correlation of laser Doppler wave patterns with underlying microvascular anatomy. J Invest Dermatol 95: 283-286, 1990.
5. Brick PL, Howlett AC, Beinfeld MC. Synthesis and release of vasoactive intestinal polypeptide (VIP) by mouse neuroblastoma cells: modulation by cyclic nucleotides and ascorbic acid. Peptides 6: 1075-1078, 1985.
6. Carberry PA, Shepherd AM, Johnson JM. Resting and maximal forearm skin blood flows are reduced in hypertension. Hypertension 20: 349-355, 1992.
7. Dillon PF, Root-Bernstein RS, Lieder CM. Ascorbate enhancement of H1 histamine receptor sensitivity coincides with ascorbate oxidation inhibition by histamine receptors. Am J Physiol Cell Physiol 291: C977-C984, 2006.
8. Farrell DM, Bishop VS. Permissive role for nitric oxide in active thermoregulatory vasodilation in rabbit ear. Am J Physiol Heart Circ Physiol 269: H1613-H1618, 1995.
9. Farrell DM, Bishop VS. The roles of cGMP and cAMP in active thermoregulatory vasodilation. Am J Physiol Regul Integr Comp Physiol 272: R975-R981, 1997.
10. Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113: 1708-1714, 2006.
11. Grant R, Holling H. Further observations on the vascular responses of the human limb to body warming: evidence for sympathetic vasodilator nerves in the normal subject. Clin Sci (Lond) 3: 273-285, 1938.
12. Grider JR, Murthy KS, Jin JG, Makhlouf GM. Stimulation of nitric oxide from muscle cells by VIP: prejunctional enhancement of VIP release. Am J Physiol Gastrointest Liver Physiol 262: G774-G778, 1992.
13. G-hydroxy-L-arginine in alveolar macrophages: implications for the utilization of L-arginine for nitric oxide synthesis. FEBS Lett 359: 251-254, 1995.
14. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 281: 627-630, 1992.
15. Heller R, Unbehaun A, Schellenberg B, Mayer B, Werner-Felmayer G, Werner ER. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 276: 40-47, 2001.
16. Holowatz LA, Kenney WL. Upregulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation in hypertensive humans. J Physiol 581:863-72, 2007.
17. Holowatz LA, Thompson CS, Kenney WL. Acute ascorbate supplementation alone or combined with arginase inhibition augments reflex cutaneous vasodilation in aged human skin. Am J Physiol Heart Circ Physiol 291: H2965-H2970, 2006.
18. Holowatz LA, Thompson CS, Kenney WL. L-Arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin. J Physiol 574: 573-581, 2006.
19. Holowatz LA, Thompson CS, Minson CT, Kenney WL. Mechanisms of acetylcholine-mediated vasodilatation in young and aged human skin. J Physiol 563: 965-973, 2005.
20. Kellogg DL Jr, Crandall CG, Liu Y, Charkoudian N, Johnson JM. Nitric oxide and cutaneous active vasodilation during heat stress in humans. J Appl Physiol 85: 824-829, 1998.
21. Kellogg DL Jr, Pergola PE, Piest KL, Kosiba WA, Crandall CG, Grossmann M, Johnson JM. Cutaneous active vasodilation in humans is mediated by cholinergic nerve cotransmission. Circ Res 77: 1222-1228, 1995.
22. Kenney WL, Kamon E, Buskirk ER. Effect of mild essential hypertension on control of forearm blood flow during exercise in the heat. J Appl Physiol 56: 930-935, 1984.
23. Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278: 22546-22554, 2003.
24. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111: 1201-1209, 2003.
25. Lassegue B, Griendling KK. Reactive oxygen species in hypertension: an update. Am J Hypertens 17: 852-860, 2004.
26. Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S, Takeshita A. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 38: 1307-1310, 2001.
27. McCord GR, Cracowski JL, Minson CT. Prostanoids contribute to cutaneous active vasodilation in humans. Am J Physiol Regul Integr Comp Physiol 291: R596-R602, 2006.
28. Munzel T, Daiber A, Ullrich V, Mulsch A. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol 25: 1551-1557, 2005.
29. Roddie IC, Shepherd JT, Whelan RF. The contribution of constrictor and dilator nerves to the skin vasodilatation during body heating. J Physiol 136: 489-497, 1957.
30. Shastry S, Dietz NM, Halliwill JR, Reed AS, Joyner MJ. Effects of nitric oxide synthase inhibition on cutaneous vasodilation during body heating in humans. J Appl Physiol 85: 830-834, 1998.
31. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97: 2222-2229, 1998.
32. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A. Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38: 274-279, 2001.
33. Toth M, Kukor Z, Valent S. Chemical stabilization of tetrahydrobiopterin by L-ascorbic acid: contribution to placental endothelial nitric oxide synthase activity. Mol Hum Reprod 8: 271-280, 2002.
34. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, Pritchard KA Jr. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 95: 9220-9225, 1998.
35. Warnholtz A, Wendt M, August M, Munzel T. Clinical aspects of reactive oxygen and nitrogen species. Biochem Soc Symp 71: 121-133, 2004.
36. Wilkins BW, Holowatz LA, Wong BJ, Minson CT. Nitric oxide is not permissive for cutaneous active vasodilatation in humans. J Physiol 548: 963-969, 2003.
37. Wong BJ, Minson CT. Neurokinin-1 receptor desensitisation attenuates cutaneous active vasodilatation in humans. J Physiol 577: 1043-1051, 2006.
38. Wong BJ, Wilkins BW, Minson CT. H1 but not H2 histamine receptor activation contributes to the rise in skin blood flow during whole body heating in humans. J Physiol 560: 941-948, 2004.